FDA approves CryoLife's heart patch

08/12/2009 | Forbes

The FDA granted approval to CryoLife for its CryoPatch SG, a human cardiac patch designed to repair or reconstruct the heart's right ventricular outflow tract, a surgery often done for pediatric patients with congenital heart defects. The company plans to start shipping the product late in the third quarter.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC